BESINS HEALTHCARE PHARMTECH
0736.939.187 · rovalta.com · 26/09/2026
ACTIVE
BESINS HEALTHCARE PHARMTECH
Financial year 2025 · Closed on 31/12/2025
Net result-6,3 M €-18,4 %over 1 year
Revenue7,6 M €+25,3 %over 1 year
Equity-9,5 M €-238,3 %over 1 year
Workforce41,1 ETP+22,7 %over 1 year
Overview
Identity
Source · BCE/KBOBESINS HEALTHCARE PHARMTECH is a Public limited company incorporated in 2019. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Seraing. It employs on average 41,1 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0736.939.187
- Incorporation
- 30/10/2019
- Legal form
- Public limited company
- Registered office
- Rue Louis Plescia 9
4102 Seraing · WallonieSee on map - Contributed capital
- 1 331 695,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 41,1 ETP
Activities (NACE)
Joint committees (2)
- 116
- 207
Contacts
1 public detail availableLog in to view
Signals
Healthy social debts
Financials
Source · NBB, 6 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 7,6 M € | +25.3% | 6 M € | – | – | – | |||
| EBITDA | -3,2 M € | -23.3% | -2,6 M € | -2210% | -110,8 k € | -122% | 502,2 k € | +70.7% | 294,3 k € |
| Operating result | -5,7 M € | -19.5% | -4,7 M € | -87.7% | -2,5 M € | -152% | -1 M € | -97.1% | -508,3 k € |
| Net result | -6,3 M € | -18.4% | -5,3 M € | -88.9% | -2,8 M € | -259% | -785 k € | -49.7% | -524,4 k € |
| Balance sheet | |||||||||
| Equity | -9,5 M € | -238% | -2,8 M € | -205% | 2,7 M € | -55.9% | 6 M € | +125% | 2,7 M € |
| Total assets | 23,7 M € | -12.7% | 27,1 M € | -10.4% | 30,3 M € | -23.6% | 39,6 M € | +141% | 16,4 M € |
| Cash | 121,9 k € | – | 791 k € | +39.1% | 568,5 k € | -86.7% | 4,3 M € | ||
| Debts | 33,1 M € | +11.0% | 29,9 M € | +8.2% | 27,6 M € | -17.7% | 33,5 M € | +144% | 13,7 M € |
| Other | |||||||||
| Workforce | 41,1 ETP | +22.7% | 33,5 ETP | +26.9% | 26,4 ETP | -3.6% | 27,4 ETP | +33.7% | 20,5 ETP |
Board of directors
Source · NBB, accounts to 31/12/2025Other companies at this address
Rue Louis Plescia 9 4102 Seraing| Company | CBE no. |
|---|---|
EYED PHARMA● Active | 0508.599.605 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 30/10/2019 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 15 months |
| Filing date | 15/07/2026 | 28/07/2025 | 16/07/2024 | 28/06/2023 | 23/08/2022 | 31/08/2021 |
| General meeting | 29/06/2026 | 03/07/2025 | 28/06/2024 | 13/06/2023 | 14/06/2022 | 20/08/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 29/06/2026 | 15/07/2026 | French | |
| Abridged model | 31/12/2024 | 03/07/2025 | 28/07/2025 | French | |
| Abridged model | 31/12/2023 | 28/06/2024 | 16/07/2024 | French | |
| Abridged model | 31/12/2022 | 13/06/2023 | 28/06/2023 | French | |
| Abridged model | 31/12/2021 | 14/06/2022 | 23/08/2022 | French | |
| Abridged model | 31/12/2020 | 20/08/2021 | 31/08/2021 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/2025Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other27/07/2026STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates23/07/2026DEMISSIONS, NOMINATIONS
- Other01/07/2026STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Capital / shares30/06/2026CAPITAL, ACTIONS
- Mandates06/05/2026DEMISSIONS, NOMINATIONS
- Mandates18/11/2025DEMISSIONS, NOMINATIONS
- Mandates23/11/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Mandates04/04/2023DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-6,3 M €↓
- 2024Annual accounts 2024-5,3 M €↓
- 2023Annual accounts 2023-2,8 M €↓
- 2022Annual accounts 2022-785 k €↓
- 2021Annual accounts 2021-524,4 k €
- 30/10/2019IncorporationPublic limited company